Used in research and development for treating autoimmune diseases such as psoriasis, inflammatory bowel disease (IBD), and multiple sclerosis. It works by specifically binding to the interleukin-23 (IL-23) cytokine, blocking its activity and reducing inflammation. This antibody serves as a reference standard in bioassays, immunoassays, and pharmacokinetic studies during the development of biosimilars or new anti-IL-23 therapeutics. It is also employed in target validation and mechanism-of-action studies in preclinical research.